Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by HARKNESS, A. J. L.
Right arrow Articles by GRAHAME, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HARKNESS, A. J. L.
Right arrow Articles by GRAHAME, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1977 British Society for Rheumatology

other

A TRIAL OF FEPRAZONE IN ANKYLOSING SPONDYLITIS

A. J. L. HARKNESS*, H. C. BURRY{dagger} and R. GRAHAME

Guy's Arthritis Research Unit, Guy's Hospital London, SE1 9RT

Correspondence to: *Present address: Alfred Hospital, Prahan 3181, Melbourne, Victoria, Australia.

Feprazone, a non-steroidal anti-inflammatory drug, was compared with indomethacin in a double-blind cross-over trial in 24 patients with ankylosing spondylitis, over eight weeks. Both regimes caused significant reduction in pain. There were fewer side-effects and more patient preferences with feprazone but these differences did not reach statistical significance.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.